ArticleJournal of multidisciplinary healthcare2025
Worldwide Research Trends on the Immunotherapy-Based Treatment of Ovarian Cancers: A Bibliometric and Visual Analysis.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Current trends and future prospects in the use of immunotherapy in ovarian cancer.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Immunotherapy-based treatment has shown significant clinical potential in various cancers. This study provides a comprehensive bibliometric analysis of the immunotherapy landscape in ovarian cancer over the last decade, identifying leading trends, influential contributors, and key areas of development. Methods: A systematic literature search was conducted in the Web of Science Core Collection for publications on immunotherapy drugs used in ovarian cancer between 2014 and 2024. Analytical tools such as VOSviewer, CiteSpace, and the R-based Bibliometrix package were employed to visualize trends, collaborations, and major contributions. Results: Our dataset of 2123 publications from 2014 to 2024 highlights a rise and stabilization in publication output, peaking in 2022. Leading journals included Conclusion: This bibliometric analysis maps the growing research interest in immunotherapy-based approaches for ovarian cancer, highlighting the field's collaborative and multidisciplinary nature. The findings provide a foundation for identifying influential themes and guiding future investigations into resistance mechanisms and personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.